{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=LCM&page=5", "query": { "intervention": "LCM", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 98, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=LCM&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=LCM&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T22:31:17.175Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01047189", "title": "Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "clindamycin phosphate 1.2% and tretinoin 0.025%", "type": "DRUG" }, { "name": "clindamycin 1% gel", "type": "DRUG" }, { "name": "tretinoin 0.025% cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 26, "start_date": "2009-03", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2018-09-10", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01047189" }, { "nct_id": "NCT01400867", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections, Pediatrics" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam", "type": "DRUG" }, { "name": "Cephalexin or Clindamycin or Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 163, "start_date": "2011-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400867" }, { "nct_id": "NCT04198129", "title": "The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Jaw Fractures", "Infection" ], "interventions": [ { "name": "Antibiotic treatment (Unasyn or Cleocin)", "type": "DRUG" }, { "name": "Antibiotic treatment (Augmentin or Cleocin)", "type": "DRUG" }, { "name": "Control Group", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2020-10-01", "completion_date": "2022-03-20", "has_results": false, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04198129" }, { "nct_id": "NCT00964223", "title": "A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Clindamycin and benzoyl peroxide gel (Duac® Topical Gel)", "type": "DRUG" }, { "name": "benzoyl peroxide and adapalene gel (EPIDUO™ Gel)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2009-07", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 2, "location_summary": "Rockville, Maryland • Warren, Michigan", "locations": [ { "city": "Rockville", "state": "Maryland" }, { "city": "Warren", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00964223" }, { "nct_id": "NCT03333408", "title": "Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Salivary Duct" ], "interventions": [ { "name": "Postoperative Oral Antibiotics (Clindamycin or Augmentin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Our Lady of the Lake Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-06-15", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2023-11-01", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03333408" }, { "nct_id": "NCT02809131", "title": "Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sick Sinus Syndrome", "Complete Heart Block", "Syncope", "Chronic Systolic Heart Failure" ], "interventions": [ { "name": "polymixin/bacitracin", "type": "DRUG" }, { "name": "cephalexin, or levofloxacin, or clindamycin", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1010, "start_date": "2016-04-01", "completion_date": "2021-09-30", "has_results": true, "last_update_posted_date": "2022-05-09", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02809131" }, { "nct_id": "NCT00530855", "title": "Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "16 Years to 70 Years" }, "enrollment_count": 322, "start_date": "2008-02", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2018-07-18", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 77, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Northport, Alabama + 66 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00530855" }, { "nct_id": "NCT06120140", "title": "Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Amivantamab IV", "type": "DRUG" }, { "name": "Amivantamab SC", "type": "DRUG" }, { "name": "Lazertinib", "type": "DRUG" }, { "name": "Doxycycline", "type": "DRUG" }, { "name": "Minocycline", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Noncomedogenic skin moisturizer", "type": "OTHER" }, { "name": "Ruxolitinib", "type": "OTHER" }, { "name": "Tacrolimus", "type": "OTHER" }, { "name": "Zinc gluconate", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" }, { "name": "Clobetasol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2024-02-16", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 28, "location_summary": "Chandler, Arizona • Duarte, California • Fullerton, California + 25 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06120140" }, { "nct_id": "NCT00664248", "title": "A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "IDP-110", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Benzoyl peroxide", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dow Pharmaceutical Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 1414, "start_date": "2006-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2008-04-22", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00664248" }, { "nct_id": "NCT00000717", "title": "The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pneumonia, Pneumocystis Carinii", "HIV Infections" ], "interventions": [ { "name": "Primaquine", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 50, "start_date": null, "completion_date": "1991-11", "has_results": false, "last_update_posted_date": "2012-10-19", "last_synced_at": "2026-10-30T22:31:17.175Z", "location_count": 7, "location_summary": "Los Angeles, California • San Francisco, California • Chicago, Illinois + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000717" } ] }